A parallel-group, phase 1b, observer-blind, two-arm study to compare the safety and tolerability of two doses of S-151128 intravenous infusion formulation with placebo in male and female patients aged 40 to 75 years with knee osteoarthritis
Latest Information Update: 17 Oct 2025
At a glance
- Drugs S 151128 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Shionogi
Most Recent Events
- 17 Oct 2025 New trial record